|
|
Post by slugworth008 on Apr 27, 2016 19:44:49 GMT -5
This is just the kind of gorilla warfare I was thinking of. LOL! Hunter S. Thompson has returned!!! |
|
|
|
Post by babaoriley on Apr 28, 2016 11:39:29 GMT -5
Hate to run into those two in the jungle! And what's the subliminal message, inhaler + human = skull? Spiro, really!  |
|
|
|
Post by mnholdem on Apr 28, 2016 14:22:05 GMT -5
Perhaps there is a subliminal message here: It's the guys with the inhalers who win in the end!  |
|
|
|
Post by spiro on Apr 28, 2016 21:03:23 GMT -5
Did it ever occur to you guys that Spiro might be taking African Medicine Man classes. That little peace pipe is damn good device to smoke after eating. Mnholdem knows his stuff, Spiro has been a winner since that first day, when he started using Afrezza.
Spiro here, a temporary financial loser, but a big time winner with his diabetes treatment.
|
|
|
|
Post by centralcoastinvestor on Apr 28, 2016 21:18:28 GMT -5
Did it ever occur to you guys that Spiro might be taking African Medicine Man classes. That little peace pipe is damn good device to smoke after eating. Mnholdem knows his stuff, Spiro has been a winner since that first day, when he started using Afrezza. Spiro here, a temporary financial loser, but a big time winner with his diabetes treatment. Now that you are an African Medicine Man in training, could you cast a curse on the shorts for us. |
|
|
|
Post by mnholdem on Apr 28, 2016 21:21:48 GMT -5
Your photo reminds me of the power of imagery. That's why I think that management may have selected the perfect agency for marketing Afrezza. IMO, they have a message that fits MannKind to a "T":
When your clients are changing standards, standard just doesn’t cut it. We beyond because that’s what our clients deserve. They do extraordinary work that changes people’s lives. So we give them extraordinary work that changes minds. That’s just who we are. And it’s the only way we work.
Curious, We explore - We’re perfectly comfortable with the unfamiliar. We’re inspired by the unknown. The pursuit of the new gets us up in the morning.
Authentic, We create - We’re prolifically original. We have a genuine yen to show it how it’s never been seen. To say it in a whole new voice.
Boldly, We transform - We turn pure data into mind-changing messages. Raw research into systematic strategy. And scientific innovations into powerful brands.
---
With Afrezza, we need "to show it how it’s never been seen. To say it in a whole new voice." Spiro is on the right track with his message because he thinks outside the box.
Although Mrs. Spiro might argue that he is just outside of his cage.
|
|
|
|
Post by centralcoastinvestor on Apr 29, 2016 9:43:52 GMT -5
Your photo reminds me of the power of imagery. That's why I think that management may have selected the perfect agency for marketing Afrezza. IMO, they have a message that fits MannKind to a "T":
When your clients are changing standards, standard just doesn’t cut it. We beyond because that’s what our clients deserve. They do extraordinary work that changes people’s lives. So we give them extraordinary work that changes minds. That’s just who we are. And it’s the only way we work.
Curious, We explore - We’re perfectly comfortable with the unfamiliar. We’re inspired by the unknown. The pursuit of the new gets us up in the morning.
Authentic, We create - We’re prolifically original. We have a genuine yen to show it how it’s never been seen. To say it in a whole new voice.
Boldly, We transform - We turn pure data into mind-changing messages. Raw research into systematic strategy. And scientific innovations into powerful brands.
---
With Afrezza, we need "to show it how it’s never been seen. To say it in a whole new voice." Spiro is on the right track with his message because he thinks outside the box.
Although Mrs. Spiro might argue that he is just outside of his cage.
Mnholdem, in all of the noise generated by the shorts and naysayers, I had forgotten about the fact that Mannkind gets to reload on the whole advertising campaign. Your post made me smile. Gone is the "Surprise, it's insulin" slogan. I remember how disappointed I was when I first heard the slogan. It seemed so stale. As it turns out, perhaps it was meant to be stale. Grrrr. I hope the new ad agency really hits it out of the park. Based on what I read from your post, I think they will. |
|
|
|
Post by kball on Apr 29, 2016 10:27:27 GMT -5
Your photo reminds me of the power of imagery. That's why I think that management may have selected the perfect agency for marketing Afrezza. IMO, they have a message that fits MannKind to a "T":
When your clients are changing standards, standard just doesn’t cut it. We beyond because that’s what our clients deserve. They do extraordinary work that changes people’s lives. So we give them extraordinary work that changes minds. That’s just who we are. And it’s the only way we work.
Curious, We explore - We’re perfectly comfortable with the unfamiliar. We’re inspired by the unknown. The pursuit of the new gets us up in the morning.
Authentic, We create - We’re prolifically original. We have a genuine yen to show it how it’s never been seen. To say it in a whole new voice.
Boldly, We transform - We turn pure data into mind-changing messages. Raw research into systematic strategy. And scientific innovations into powerful brands.
---
With Afrezza, we need "to show it how it’s never been seen. To say it in a whole new voice." Spiro is on the right track with his message because he thinks outside the box.
Although Mrs. Spiro might argue that he is just outside of his cage.
Mnholdem, in all of the noise generated by the shorts and naysayers, I had forgotten about the fact that Mannkind gets to reload on the whole advertising campaign. Your post made me smile. Gone is the "Surprise, it's insulin" slogan. I remember how disappointed I was when I first heard the slogan. It seemed so stale. As it turns out, perhaps it was meant to be stale. Grrrr. I hope the new ad agency really hits it out of the park. Based on what I read from your post, I think they will. For those with a (really) dark sense of humor like mine... "Surprise, its your brokerage statement" |
|
|
|
Post by sportsrancho on Apr 29, 2016 10:58:53 GMT -5
I'd rather go with " Surprise it's a lawsuit! "
|
|
|
|
Post by kball on Apr 29, 2016 11:01:30 GMT -5
I'd rather go with " Surprise it's a lawsuit! " Yeah i liked that one too and probably stole the general idea and turned it pitch black. Wasn't it Jstokcton who brilliantly came up wit that one just after divorce? |
|
|
|
Post by sportsrancho on Apr 29, 2016 11:07:56 GMT -5
I'd rather go with " Surprise it's a lawsuit! " Yeah i liked that one too and probably stole the general idea and turned it pitch black. Wasn't it Jstokcton who brilliantly came up wit that one just after divorce? Yes, I think it was him! Love it. Saw it on ST |
|
|
|
Post by BlueCat on Apr 29, 2016 19:50:23 GMT -5
Yeah i liked that one too and probably stole the general idea and turned it pitch black. Wasn't it Jstokcton who brilliantly came up wit that one just after divorce? Yes, I think it was him! Love it. Saw it on ST My friends- surprise! It was your friendly neighborhood Q |
|
|
|
Post by sportsrancho on Apr 29, 2016 20:06:04 GMT -5
Yes, I think it was him! Love it. Saw it on ST My friends- surprise! It was your friendly neighborhood Q OMG that's right:-)) Very witty! |
|
|
|
Post by cm5 on Apr 30, 2016 7:46:03 GMT -5
Clinical inertia is a global phenomenon, which is putting people with Type 2 diabetes at further risk of preventable complications associated with the condition.
More proof of the obvious, and the obvious need for global availability/prescribing of Afrezza-----
See summary below of:
K. Khunti, A. Nikolajsen, B. L. Thorsted, M. Andersen, M. J. Davies, S. K. Paul. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes, Obesity and Metabolism, 2016; 18 (4): 401 DOI: 10.1111/dom.12626
"People with Type 2 diabetes are being 'let down' because they are being forced to wait for further treatment when needed.
Research has shown the average waiting time for increased treatment from the start of insulin is 3.7 years.
Maintaining tight control of blood sugars in people with Type 2 diabetes can lead to significant reductions in related complications, previous evidence has shown."
However 'clinical inertia', which is the term given for the delay of increasing medication needed for patients, is preventing this from happening, according to a study published in the Diabetes, Obesity and Metabolism journal.
The research was carried out by NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East Midlands, an organisation which turns research into cost-saving and high-quality care through cutting-edge innovation.
Professor Kamlesh Khunti, Director of CLAHRC East Midlands and Professor of Primary Care Diabetes & Vascular Medicine at the University of Leicester based at the Leicester Diabetes Centre, said: "Of the 11,000 patients we studied, only a third of those needing further medication were actually given it.
"Clinical inertia is a global phenomenon, which is putting people with Type 2 diabetes at further risk of preventable complications associated with the condition.
"Failure by healthcare professionals to intensify medication in the pursuit of tighter glycaemic control is due to a number of complex reasons related to patient and health care professional factors. However, we need to make great efforts to reverse these trends and improve patients reaching tight glucose targets from diagnosis of diabetes"
The study concluded that more should be done to avoid clinical inertia and patients should have their treatment intensified where appropriate.
Long-term complications and mortality associated with Type 2 diabetes can be significantly reduced if therapies are initiated earlier."
|
|
|
|
Post by agedhippie on Apr 30, 2016 10:47:13 GMT -5
That's unreadable! Here is a link to the article itself - www.sciencedaily.com/releases/2016/04/160426092128.htmAnd here is a link to the paper it is talking about - onlinelibrary.wiley.com/doi/10.1111/dom.12626/fullThe executive summary is that doctors do not push Type 2 diabetics to achieve better control. Unfortunately the protocols used in the NHS have changed during the periods they are looking at so the numbers may no longer be correct. GPs (PCPs) are now partially paid on the number of diabetic patients they have in range so there is a financial incentive to treat more aggressively. |
|
